Valneva SE (VALN) Financials

VALN Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 426.8 million 338.4 million
Dec. 31, 2025 468.2 million 343.6 million
Sept. 30, 2025 526.0 million 349.4 million
June 30, 2025 557.1 million 337.3 million

VALN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -647467 ?
Dec. 31, 2025 -56.6 million ?
Sept. 30, 2025 -21.3 million ?
June 30, 2025 -4.8 million ?

VALN Net Income

No data available :(

VALN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 120.8 million 188.2 million 31.2 million
Dec. 31, 2025 128.7 million 189.3 million 33.0 million
Sept. 30, 2025 168.4 million 127.8 million 33.0 million
June 30, 2025 190.1 million 144.2 million 33.6 million

VALN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 98.6 million
Dec. 31, 2025 101.8 million
Sept. 30, 2025 100.8 million
June 30, 2025 90.7 million

VALN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 288782 17.7 million 17.3 million 8.0 million
Dec. 31, 2025 1.5 million 30.0 million 19.4 million 10.3 million
Sept. 30, 2025 783917 32.0 million 22.1 million 9.7 million
June 30, 2025 1.5 million 20.6 million 23.6 million 11.7 million

VALN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 35.4 million 30.0 million
Dec. 31, 2025 56.0 million 42.3 million
Sept. 30, 2025 34.5 million 28.1 million
June 30, 2025 57.0 million 28.4 million

VALN

Price: $5.36

52 week price:
5.06
12.25

Earnings Per Share: -1.86 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: France

Volume: 8187

Market Capitalization: 488.0 million

Links: